Vajdic CM, McDonald SP, McCredie MR, et al: Cancer incidence before and after kidney transplantation. .JAMA 296::2823. ,2006. .
Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. .N Engl J Med 348::1681. ,2003. .
Geusau A, Dunkler D, Messeritsch E, et al: Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy. .Int J Dermatol 47::918. ,2008. .
Nasca MR, Innocenzi D, Micali G: Subungual squamous cell carcinoma of the toe: report on three cases. .Dermatol Surg 30::345. ,2004. .
Kelly KJ, Kalani AD, Storrs S, et al: Subungual squamous cell carcinoma of the toe: working toward a standardized therapeutic approach. .J Surg Educ 65::297. ,2008. .
Dalle S, Depape L, Phan A, et al: Squamous cell carcinoma of the nail apparatus: clinicopathological study of 35 cases. .Br J Dermatol 156::871. ,2007. .
Robinette JW, Day F III, Hahn P Jr: Subungual squamous cell carcinoma mistaken for a verruca. .JAPMA 89::435. ,1999. .
Boukamp P: Non-melanoma skin cancer: what drives tumor development and progression?. Carcinogenesis 26::1657. ,2005. .
Guidance on Cancer Services: Skin Tumours Including Melanoma, National Institute for Health and Clinical Excellence, London, England. ,2006. . Reference NO959.
Nguyen TH, Ho DQ: Nonmelanoma skin cancer. .Curr Treat Options Oncol 3::193. ,2002. .
Mullen JT, Feng L, Xing Y, et al: Invasive squamous cell carcinoma of the skin: defining a high-risk group. .Ann Surg Oncol 13::902. ,2006. .
Attiyeh FF, Shah J, Booher RJ, et al: Subungual squamous cell carcinoma. .JAMA 241::262. ,1979. .
Shelley WB, Wood MG: Transformation of the common wart into squamous cell carcinoma in a patient with primary lymphedema. .Cancer 48::820. ,1981. .
Tosti A, La Placa M, Fanti PA, et al: Human papillomavirus type 16-associated periungual squamous cell carcinoma in a patient with acquired immunodeficiency syndrome. .Acta Derm Venereol 74::478. ,1994. .
Ramsay H, Reece S, Fryer A, et al: Seven-year prospective study of nonmelanoma skin cancer incidence in U.K. renal transplant recipients. .Transplantation 84::437. ,2007. .
Carroll RP, Ramsay H, Fryer A, et al: Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. .Am J Kidney Dis 41::676. ,2003. .
Otley CC, Coldiron BM, Stasko T, et al: Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. .Arch Dermatol 137::459. ,2001. .
Hojyo-Tomoka MT, Chanussot-Deprez C, Vega-Memije ME, et al: Subungual squamous cell carcinoma of the first toe. .Int J Dermatol 45::1118. ,2006. .
Zaiac MN, Weiss E: Mohs micrographic surgery of the nail unit and squamous cell carcinoma. .Dermatol Surg 27::246. ,2001. .
Goldminz D, Bennett RG: Mohs micrographic surgery of the nail unit. .J Dermatol Surg Oncol 18::721. ,1992. .
Leibovitch I, Huilgol S, Selva D, et al: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia: I. Experience over 10 years. .J Am Acad Dermatol 53::253. ,2005. .
Holgado RD, Ward SC, Suryaprasad SG: Squamous cell carcinoma of the hallux. .JAPMA 90::309. ,2000. .
Brantsch KD, Meisner C, Schonfisch B, et al: Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. .Lancet Oncol 9::713. ,2008. .
Peterson SR, Layton EG, Joseph AK: Squamous cell carcinoma of the nail unit with evidence of bony involvement: a multidisciplinary approach to resection and reconstruction. .Dermatol Surg 30::218. ,2004. .
It is accepted that immunosuppressant therapy after organ transplantation is associated with an increase risk of neoplasm. Subungual squamous cell carcinoma of the toe is a rare condition and has not previously been reported, to our knowledge, in patients undergoing immunosuppressant therapy. The objective of this case study is to report the clinical and histopathologic findings and the multidisciplinary treatment approach for a case of subungual squamous cell carcinoma of the toe in an organ transplant recipient undergoing immunosuppressant drug therapy. (J Am Podiatr Med Assoc 100(4): 304–308, 2010)